| Pre-Intervention Stage (N = 917) | Post-Intervention Stage (N = 826) | ||
Intervention (n = 437) | Control (n = 480) | Intervention (n = 436) | Control (n = 390) | |
Age. Mean (IC 95%) | 63.75 (61.75 - 65.75) | 65.13 (63.44 - 66.82) | 64.55 (63.37 - 65.73) | 64.90 (61.93 - 67.87) |
% Women (IC 95%) | 67.04 (63.19 - 70.68) | 62.50 (54.64 - 69.75) | 60.77 (55.71 - 65.62) | 62.82 (55.22 - 69.82) |
% HBP (IC 95%) | 47.59 (42.86 - 52.37) | 38.75 (34.62 - 43.04) | 47.01 (43.62 - 50.44) | 44.10 (37.38 - 51.04) |
% Diabetes (IC 95%) | 10.52 (8.40 - 13.10) | 10.0 (6.58 - 14.90) | 12.38 (9.77 - 15.57) | 9.48 (7.23 - 12.34) |
% Dyslipidaemia (IC 95%) | 34.55 (28.70 - 40.91) | 29.37 (25.61 - 33.44) | 35.77 (32.42 - 39.28) | 28.97 (24.16 - 34.30) |
% Use of Tobacco (IC 95%) | 27.11 (22.64 - 32.10)a | 20.25 (14.42 - 27.67)b | 19.93 (15.20 - 25.69)c | 18.82 (14.20 - 24.51)d |